The Diabetes Control and Complications Trial (DCCT) established the importa
nce of hyperglyemia and other consequences of insulin deficiency in the pat
hogenesis of diabetic neuropathy, but the precise mechanisms by which metab
olic alterations produce peripheral nerve fiber damage and loss remain uncl
ear. Emerging data from human and animal studies suggest that glucose-deriv
ed oxidative stress may play a central role, linking together many of the o
ther currently invoked pathogenetic mechanisms such as the aldose reductase
and glycation pathways, vascular dysfunction, and impaired neurotrophic su
pport. These relationships suggest combinations of pharmacological interven
tions that may synergistically protect the peripheral nervous system (PNS)
against the metabolic derangements of diabetes mellitus. (C) 1999 Elsevier
Science B.V. All rights reserved.